Arhgef9 Antibody (Center) Blocking Peptide
€293.00
In stock
SKU
AC-BP2713c
Background:
ARHGEF9 belongs to a family of Rho-like GTPases that act as molecular switches by cycling from the active GTP-bound state to the inactive GDP-bound state. These proteins are key regulators of the actin cytoskeleton and are involved in cell signaling.
Other Names: Rho guanine nucleotide exchange factor 9, Collybistin, Rac/Cdc42 guanine nucleotide exchange factor 9, Arhgef9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2713c was selected from the Center region of human Arhgef9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: Q9QX73
Gene Name: Arhgef9
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Xiang,S., J. Mol. Biol. 359 (1), 35-46 (2006)Harvey,K., J. Neurosci. 24 (25), 5816-5826 (2004)Grosskreutz,Y., Biol. Chem. 382 (10), 1455-1462 (2001)Kins,S., Nat. Neurosci. 3 (1), 22-29 (2000)
ARHGEF9 belongs to a family of Rho-like GTPases that act as molecular switches by cycling from the active GTP-bound state to the inactive GDP-bound state. These proteins are key regulators of the actin cytoskeleton and are involved in cell signaling.
Other Names: Rho guanine nucleotide exchange factor 9, Collybistin, Rac/Cdc42 guanine nucleotide exchange factor 9, Arhgef9
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP2713c was selected from the Center region of human Arhgef9. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Type: Synthetic peptide
Primary Accession: Q9QX73
Gene Name: Arhgef9
Format: Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.
Bio References:
Xiang,S., J. Mol. Biol. 359 (1), 35-46 (2006)Harvey,K., J. Neurosci. 24 (25), 5816-5826 (2004)Grosskreutz,Y., Biol. Chem. 382 (10), 1455-1462 (2001)Kins,S., Nat. Neurosci. 3 (1), 22-29 (2000)
| Is Featured? | No |
|---|
Write Your Own Review